RNASEL and inflammatory bowel disease: Novel OAS1 patient mutations were linked to hyperactivation of RNase L, leading to polymorphic autoinflammatory immunodeficiency, a disease characterized by several symptoms, including those of IBD (Magg et al. 2021) (Figure 4).